Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant "XDR" tuberculosis patients on bedaquiline during COVID-19 pandemic

被引：3
|
作者：
Udwadia, Zarir F. [1 ]
Sharma, Samridhi [1 ]
Mullerpattan, Jai B. [1 ]
Gajjar, Ishita [1 ]
Pinto, Lancelot [1 ]
机构：
[1] PD Hinduja & Med Res Ctr, Dept Pulm Med, Mumbai, Maharashtra, India
来源：
LUNG INDIA | 2021年 / 38卷 / 01期
关键词：
D O I：
10.4103/lungindia.lungindia_464_20
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：98 / +
页数：2
相关论文
共 50 条
  • [1] Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis
    Vasilyeva, Irina
    Mariandyshev, Andrei
    Kazennyy, Boris
    Davidaviciene, Edita
    Lounis, Nacer
    Keim, Sofia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [2] Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis (xdr-tb)
    Gaida, R.
    Truter, I.
    Peters, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S12 - S13
  • [3] Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India
    Udwadia, Zarir F.
    Ganatra, Shashank
    Mullerpattan, Jai B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [4] Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis
    Gaida, Razia
    Truter, Ilse
    Peters, Charles A.
    [J]. SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2020, 35 (01)
  • [5] A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic
    Khan, Maria
    Khattak, Maria Tasneem
    Gul, Amina
    Riaz, Muhammad
    Zahra, Fatima tu
    [J]. INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2024, 18 (01): : 24 - 28
  • [6] Use of bedaquiline in the treatment of a patient with extensively drug-resistant pulmonary tuberculosis
    Kostanta, Soultana
    Manika, Katerina
    Papavasileiou, Apostolos
    Ioannidis, Panagiotis
    Papadaki, Eleni
    Zarogoulidis, Konstantinos
    Kioumis, Ioannis
    [J]. PNEUMON, 2016, 29 (01) : 53 - 57
  • [7] Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic - Dharavi, Mumbai, India, 2020-2022
    Gomare, Mangala D.
    Bhide, Sampada
    Deshmukh, Rajesh
    Kaipilyawar, Satish
    Puri, Varsha
    Moonan, Patrick K.
    Khetade, Dilip K.
    Nyendak, Melissa
    Yeldandi, Vijay
    Smith, Jonathan P.
    Tobias, James L.
    Date, Anand
    Joshi, Rajendra
    Kumar, Ravinder
    Ho, Christine S.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (12): : 304 - 308
  • [8] Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
    Utpat, Ketaki V.
    Rajpurohit, Rakesh
    Desai, Unnati
    [J]. LUNG INDIA, 2023, 40 (01) : 19 - 23
  • [9] Administration of linezolid, bedaquiline and imipenem in treatment of patients with extensively drug-resistant tuberculosis
    Nikolayan, L. T.
    Yeghiazaryan, L. M.
    Hayrapetyan, A. O.
    Beglaryan, N. R.
    Poghosyan, V. R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort
    Guglielmetti, Lorenzo
    Le Du, Damien
    Jachym, Mathilde
    Henry, Benoit
    Martin, Diane
    Caumes, Eric
    Veziris, Nicolas
    Metivier, Nathalie
    Robert, Jerome
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 188 - 194
12345